Horizon Therapeutics today announced $140,000 in scholarships to help economically disadvantaged students from Waterford Institute of Technology and Trinity College Dublin cover their non-tuition expenses.
The scholarships will support two students in the health sciences and accounting programs at the Waterford Institute of Technology with funding dispersed in partnership with The Ireland Funds.
The Horizon Scholars program was initiated in 2019 to help talented, economically disadvantaged students by providing full scholarships, or covering the gap between a student’s financial aid and their personal ability to pay for higher education. The Scholars are chosen by partner academic institutions, assigned a Horizon employee mentor, given access to quarterly programming and have the potential to become interns and secure a job at the company. Partner institutions include Lake Forest College, Howard University, Trinity College, Waterford Institute of Technology and Asian University for Women.
In June of this year it was announced that Horizon are establishing a manufacturing facility in Waterford which will employ c.90 people. The new global biotech manufacturing operation will produce drug product for Horizon’s rare, autoimmune and severe inflammatory disease portfolio. The company announced it was purchasing the existing drug product manufacturing facility operated at present by EirGen Pharma, an OPKO health company located on IDA Ireland’s business park in Waterford to facilitate its establishment there. Some 40 of EirGen’s employees were transferring to Horizon as part of the process and are among the 90 people to have been employed at the new facility.